Amanda Adler
Professor of Diabetic Medicine and Health Policy
- Director of Diabetes Trials Unit
Recent publications
-
Accurate accounting of caplacizumab cost effectiveness – Authors' reply
Journal article
Hughes M. et al, (2021), The Lancet Haematology, 8
-
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Journal article
Adler A. et al, (2021), The Lancet, 397, 1625 - 1636
-
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Journal article
Copland E. et al, (2021), Lancet Oncol, 22, 558 - 570
-
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
Journal article
Copland E. et al, (2021), Lancet Oncol, 22, 558 - 570
-
The STEP 1 trial for weight loss: a step change in treating obesity?
Journal article
Adler AI., (2021), Nature Medicine, 27, 589 - 590